Tenet director plans $361K stock sale under Rule 144

TENET HEALTHCARE CORP (THC) is the issuer of common stock that Cecil D. Haney, a director, has notified an intent to sell under Rule 144.

Rhea-AI Filing Summary

TENET HEALTHCARE CORP (THC) is the issuer of common stock that Cecil D. Haney, a director, has notified an intent to sell under Rule 144. The notice covers 1,300 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $361,439.00 and referencing 80,519,000 shares outstanding and an approximate sale date of 08/24/2026.

The shares to be sold were acquired from the issuer as compensation via restricted stock vesting events of 322 shares on 05/07/2024 and 978 shares on 05/23/2025.

Key Figures

Shares to be sold: 1,300 shares of common stock Aggregate market value: $361,439.00 Shares outstanding: 80,519,000 shares +3 more

6 metrics

Shares to be sold 1,300 shares of common stock Number of TENET HEALTHCARE CORP shares covered by the Rule 144 notice

Aggregate market value $361,439.00 Aggregate market value of the 1,300 shares proposed to be sold

Shares outstanding 80,519,000 shares Shares outstanding referenced for TENET HEALTHCARE CORP common stock

Approximate date of sale 08/24/2026 Approximate date of the proposed Rule 144 sale

Restricted stock vesting 1 322 shares Restricted stock vesting from issuer on 05/07/2024 as compensation

Restricted stock vesting 2 978 shares Restricted stock vesting from issuer on 05/23/2025 as compensation

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 05/07/2024 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Cecil Haney."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for TENET HEALTHCARE CORP (THC)?

It discloses that director Cecil D. Haney intends to sell 1,300 shares of TENET HEALTHCARE CORP common stock under Rule 144 through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 08/24/2026.

How many THC shares are covered by Cecil D. Haney’s planned Rule 144 sale?

The notice covers 1,300 shares of TENET HEALTHCARE CORP common stock, to be sold through Fidelity Brokerage Services LLC on the NYSE, as reported in the Form 144 filing.

What is the reported market value of the THC shares in this Form 144?

The Form 144 reports an aggregate market value of $361,439.00 for the 1,300 shares of TENET HEALTHCARE CORP common stock proposed to be sold.

How were the THC shares in this Form 144 acquired by Cecil D. Haney?

The shares were acquired from the issuer as compensation via restricted stock vesting: 322 shares vested on 05/07/2024 and 978 shares vested on 05/23/2025, both identified as restricted stock vesting from the issuer.

What share count for TENET HEALTHCARE CORP is referenced in the Form 144?

The filing references 80,519,000 shares outstanding of TENET HEALTHCARE CORP common stock in connection with the planned Rule 144 sale of 1,300 shares.

Who is acting as broker and attorney-in-fact in this THC Form 144?

Fidelity Brokerage Services LLC is listed as the broker for the sale, and the Form 144 is signed by Joshua Schmitt as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Cecil Haney.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 05:16 PM EDT Accepted by SEC EDGAR 08/24/2026 - 05:15 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001769664
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TENET HEALTHCARE CORP
SEC File Number	001-07293
Address of Issuer	14201 DALLAS PARKWAY DALLAS TEXAS 75254
Phone	469-893-2200
Name of Person for Whose Account the Securities are To Be Sold	HANEY CECIL D
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1300	361439.00	80519000	08/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/07/2024	Restricted Stock Vesting	Issuer			322	05/07/2024	Compensation
Common	05/23/2025	Restricted Stock Vesting	Issuer			978	05/23/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Cecil Haney.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)